These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2034990)

  • 41. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.
    Fromm H
    Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267
    [No Abstract]   [Full Text] [Related]  

  • 42. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Feb; 27(2):95-131. PubMed ID: 6365507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS; Salen G; Shefer S
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy.
    Sharma BC; Agarwal DK; Dhiman RK; Baijal SS; Choudhuri G; Saraswat VA
    Gastroenterology; 1998 Jul; 115(1):124-8. PubMed ID: 9649467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.
    Thistle JL; Hofmann AF; Yu PY; Ott B
    Am J Dig Dis; 1977 Jan; 22(1):1-6. PubMed ID: 835542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid.
    Sackmann M; Pauletzki J; Aydemir U; Holl J; Sauerbruch T; Hasford J; Paumgartner G
    Hepatology; 1991 Dec; 14(6):1136-41. PubMed ID: 1959863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dissolution of cholesterol gallstones by bile acids in the prairie dog.
    Cohen BI; Mosbach EH; Kuroki S; McSherry CK
    Lipids; 1988 Mar; 23(3):220-4. PubMed ID: 3374276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes in the pattern of serum biliary acids and lipoprotein picture during therapy with biliary acids in cholesterol lithiasis].
    Di Mario F; Angonese C; Del Favero G; Aggio L; Meggiato T; Scalon P; Basso D; Plebani M; Burlina A; Naccarato R
    G Clin Med; 1990; 71(6-7):435-41. PubMed ID: 2258026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current status of chenodeoxycholic acid (chenodiol) therapy of cholesterol gallstones.
    Zak RA; Marks JW; Schoenfield LJ
    Semin Liver Dis; 1983 May; 3(2):132-45. PubMed ID: 6408740
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials.
    May GR; Sutherland LR; Shaffer EA
    Aliment Pharmacol Ther; 1993 Apr; 7(2):139-48. PubMed ID: 8485266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?
    Iser JH; Murphy GM; Dowling RH
    Gut; 1977 Jan; 18(1):7-15. PubMed ID: 838406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Routine determination of biliary lipid composition with the entero-test.
    Muraca M; Pazzi P; Vilei MT; Miconi L; Granato A; Cianci V; Sighinolfi D; Alvisi A; Gerunda G; Maffei Faccioli A
    Ann Chir; 1994; 48(2):197-200. PubMed ID: 8192414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo kinetics of radiolucent gallstone dissolution by oral dihydroxy bile acids.
    Senior JR; Johnson MF; DeTurck DM; Bazzoli F; Roda E
    Gastroenterology; 1990 Jul; 99(1):243-51. PubMed ID: 2344929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chenodeoxycholic acid: uses and limitations.
    Schoenfield LJ
    Hosp Pract; 1979 Oct; 14(10):57-65. PubMed ID: 478496
    [No Abstract]   [Full Text] [Related]  

  • 57. Cheno and urso compared and contrasted.
    Dowling RH
    Acta Med Port; 1983 Jan; 4(1):51-62. PubMed ID: 6337454
    [No Abstract]   [Full Text] [Related]  

  • 58. Diurnal variation in cholesterol saturation of gall-bladder bile.
    Kupfer RM; Northfield TC
    Gut; 1983 Oct; 24(10):950-3. PubMed ID: 6684613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
    Ruppin DC; Murphy GM; Dowling RH
    Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Per oral gallstone dissolution therapy].
    Sugata F
    Nihon Rinsho; 1993 Jul; 51(7):1785-90. PubMed ID: 8366596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.